title: Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease.
abstract: Restless legs syndrome (RLS) symptoms are often reported in Parkinson's disease (PD), but prevalence studies of RLS in PD are few and the results are inconsistent. In addition, clinical overlapping between RLS, "wearing-off"-related lower limb discomfort and restlessness, and akathisia complicate the clinical assessments of true RLS in PD. Underlying pathophysiology potentially shared by RLS and PD is mainly suggested by similarities in treatment response. Functional imaging studies in RLS are still inconclusive, although some authors have found subtle deficits in nigrostriatal terminal function. Long-term prospective studies of RLS cohorts will clarify whether or not RLS is associated with an increased risk for development of PD.
authors.affiliation: Department of Neurology, University of Innsbruck, Innsbruck, Austria. werner.poewe@uibk.ac.at
authors.forename: Werner
authors.initials: W
authors.lastname: Poewe
authors.forename: Birgit
authors.initials: B
authors.lastname: Högl
mesh_terms: D017109:Akathisia, Drug-Induced / Q000209:etiology; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D015331:Cohort Studies; D003342:Corpus Striatum / Q000503:physiopathology; D015259:Dopamine Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D020189:Nocturnal Myoclonus Syndrome / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D015995:Prevalence; D011595:Psychomotor Agitation / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D012148:Restless Legs Syndrome / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D020919:Sleep Disorders, Intrinsic / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D013378:Substantia Nigra / Q000503:physiopathology
chemical_list: D000978:Antiparkinson Agents; D015259:Dopamine Agents